Siler H. Panowski - Concepedia

Author

Siler H. Panowski

Allogene Therapeutics (United States)ORCID

Also Known As

Siler H Panowski, Siler H. Panowski, Siler Panowski

123

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Allogene Therapeutics (United States)Salk Institute for Biological Studies Howard Hughes Medical Institute Pfizer (United States)Sanford Burnham Prebys Medical Discovery Institute

About

Siler H. Panowski is an author at Allogene Therapeutics (United States) specializing in medicine, longevity, and gene expression.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	1.4K
2	Biology	3	3	826
3	Cell Biology	3	3	822
4	Natural Sciences	2	2	624
5	Social Sciences	1	1	48

Siler H. Panowski

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Age-Dependent Deterioration of Nuclear Pore Complexes Causes a Loss of Nuclear Integrity in Postmitotic Cells Maximiliano A. D’Angelo, Marcela Raı́ces, Siler H. Panowski, Cell ChromatinNuclear Pore ComplexesOrganelle DynamicAge-dependent DeteriorationMolecular Biology	2009	572
PHA-4/Foxa mediates diet-restriction-induced longevity of C. elegans Siler H. Panowski, Suzanne Wolff, Hugo Aguilaniu, Nature BiologyCaloric RestrictionLifespan ExtensionDevelopmental BiologyLongevity	2007	539
Intestinal Autophagy Improves Healthspan and Longevity in C. elegans during Dietary Restriction Sara Gelino, Jessica T. Chang, Caroline Kumsta, PLoS Genetics NutritionMitophagyGastroenterologyCaloric RestrictionCell Autophagy	2016	202
Optimizing Dietary Restriction for Genetic Epistasis Analysis and Gene Discovery in C. elegans William B. Mair, Siler H. Panowski, Reuben J. Shaw, PLoS ONE GeneticsFood IntakeGene DiscoveryGene CharacterizationGenomics	2009	85
Preclinical Development and Evaluation of Allogeneic CAR T Cells Targeting CD70 for the Treatment of Renal Cell Carcinoma Siler H. Panowski, Surabhi Srinivasan, Nguyêñ Duy Tân, Cancer Research	2022	84
Integrin‐linked kinase modulates longevity and thermotolerance in <i>C. elegans</i> through neuronal control of <scp>HSF</scp>‐1 Caroline Kumsta, Tsui‐Ting Ching, Mayuko Nishimura, Aging Cell Integrin-linked KinaseMolecular RegulationCytoskeletonCellular PhysiologySocial Sciences	2013	48
Allogeneic CAR T Cells Targeting DLL3 Are Efficacious and Safe in Preclinical Models of Small Cell Lung Cancer Yi Zhang, Silvia K. Tacheva-Grigorova, Janette Sutton, Clinical Cancer Research	2023	46
Preclinical Efficacy and Safety Comparison of CD3 Bispecific and ADC Modalities Targeting BCMA for the Treatment of Multiple Myeloma Siler H. Panowski, Tracy C. Kuo, Yi Zhang, Molecular Cancer Therapeutics	2019	45
Preclinical Evaluation of a Potent Anti-Bcma CD3 Bispecific Molecule for the Treatment of Multiple Myeloma Siler H. Panowski, Tracy C. Kuo, Amy Chen, Blood	2016	20
Constitutive Turbodomains enhance expansion and antitumor activity of allogeneic BCMA CAR T cells in preclinical models Regina Lin, Janette Sutton, Trevor Bentley, Science Advances	2023	17

Page 1